Failure to metformin and insulin secretagogue monotherapy: An observational cohort study

Acta Diabetologica

Volumn 47, Issue SUPPL. 1, 2010, Pages

  Pala, Laura ^a   Monami, Matteo ^a   Lamanna, Caterina ^a   Cresci, Barbara ^a   Colombi, Claudia ^a   Bardini, Gianluca ^a   Sposato, Jolanda ^a   Marchionni, Niccolò ^a   Rotella, Carlo M ^a   Mannucci, Edoardo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Failure; Monotherapy; Oral hypoglycemic drugs; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; DRUG PREFERENCE; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 78751588734     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0104-9     Document Type: Article

References (18)

1. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 9131 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
2. A Patel S MacMahon J Chalmers, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 24 2560 2572 1:CAS:528:DC%2BD1cXnt1yht7s%3D 10.1056/NEJMoa0802987 18539916 (Pubitemid 351831357)
3. UK Prospective Diabetes Study (UKPDS) Group 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 9131 854 865 10.1016/S0140-6736(98) 07037-8 (Pubitemid 28416719)
4. C Abraira WC Duckworth T Moritz 2008 Glycaemic separation and risk factor control in the Veterans affairs diabetes trial: an interim report Diabetes Obes Metab 11 150 156 10.1111/j.1463-1326.2008.00933.x 18671796
5. HC Gerstein ME Miller RP Byington, et al. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 24 2545 2559 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D 10.1056/NEJMoa0802743 18539917 (Pubitemid 351831356)
6. RC Turner CA Cull V Frighi RR Holman UK Prospective Diabetes Study (UKPDS) Group 1999 Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 281 21 2005 2012 1:CAS:528:DyaK1MXjvFOls7g%3D 10.1001/jama.281.21.2005 10359389 (Pubitemid 29254858)
7. SE Kahn SM Haffner MA Heise, et al. 2006 Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 23 2427 2443 1:CAS:528:DC%2BD28Xht12ntrzF 10.1056/NEJMoa066224 17145742 (Pubitemid 44903747)
8. DR Matthews CA Cull IM Stratton RR Holman RC Turner UK Prospective Diabetes Study (UKPDS) Group 1998 UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over 6 years Diabet Med 15 4 297 303 1:STN:280:DyaK1c3ksVOqsQ%3D%3D 10.1002/(SICI)1096-9136(199804)15:4<297::AID- DIA572>3.3.CO;2-N 9585394
9. J Chalmers S MacMahon G Mancia, et al. 1999 1999 World Health Organization-international society of hypertension guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization Clin Exp Hypertens 21 5-6 1009 1060 1:STN:280:DyaK1MzkvF2rtg%3D%3D 10423121
10. M Young J Breddy A Veves A Boulton 1994 The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study Diabetes Care 17 557 560 1:STN:280:DyaK2czmsVWmug%3D%3D 10.2337/diacare.17.6.557 8082524
11. H Blackburn 1969 Classification of the elettrocardiogram for population studies: Minnesota code J Elettrocardiol 2 305 310 1:STN:280: DyaE3c7gtFaqsg%3D%3D 10.1016/S0022-0736(69)80120-2
12. M Charlson T Szatrowski T Peterson J Gold 1994 Validation of a combined comorbidity index J Clin Epidemiol 47 1245 1251 1:STN:280:DyaK2M3jvFantQ%3D%3D 10.1016/0895-4356(94)90129-5 7722560 (Pubitemid 24361532)
13. DT Eurich SH Simpson SR Majumdar JA Johnson 2005 Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus Pharmacotherapy 25 6 810 816 1:CAS:528:DC%2BD2MXls1amur0%3D 10.1592/phco.2005. 25.6.810 15927899 (Pubitemid 40727132)
14. AA Riedel H Heien J Wogen CA Plauschinat 2007 Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy Pharmacotherapy 27 8 1102 1110 1:CAS:528:DC%2BD2sXptlKqtLw%3D 10.1592/phco.27.8.1102 17655510 (Pubitemid 47173656)
15. S Del Guerra L Marselli R Lupi, et al. 2005 Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets J Diabetes Complicat 19 1 60 64 10.1016/j.jdiacomp.2004.05.001 15642492 (Pubitemid 40092372)
16. R Lupi GS Del L Marselli, et al. 2004 Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion Am J Physiol Endocrinol Metab 286 4 E560 E567 1:CAS:528:DC%2BD2cXjtlagtbo%3D 10.1152/ajpendo.00561.2002 14625208 (Pubitemid 38374953)
17. S Del Prato C Bianchi P Marchetti 2007 β-cell function and anti-diabetic pharmacotherapy Diabetes Metab Res Rev 23 518 527 1:CAS:528:DC%2BD2sXhtlCqs7nO 10.1002/dmrr.770 17883249 (Pubitemid 350018025)
18. G Viberti SE Kahn DA Greene, et al. 2002 A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes Diabetes Care 25 10 1737 1743 1:CAS:528:DC%2BD38Xos1Wht70%3D 10.2337/diacare.25.10.1737 12351470 (Pubitemid 41071079)